Comparative evaluation of cytokines in gingival crevicular fluid and saliva of patients with aggressive periodontitis

International Journal of Biological Markers

Volumn 28, Issue 1, 2013, Pages 108-112

  Yue, Yuan ^a   Liu, Qing ^b   Xu, Chunjiao ^c   Loo, Wings T Y ^b   Wang, Min ^a   Wen, Guo ^c   Cheung, Mary N B ^d   Bai, Lan Jun ^e   Dou, Yi Ding ^d   Chow, Louis W C ^b   Hao, Liang ^a   Tian, Ye ^a   Li, Jin Le ^a   Yip, Adrian Y S ^b   Ng, Elizabeth L Y ^b  

^a SICHUAN UNIVERSITY   (China)

^b UNIMED Medical Institute and Organisation for Oncology and Translational Research   (Hong Kong)

^c CENTRAL SOUTH UNIVERSITY   (China)

^d Jin Hua Dentistry   (China)

^e SICHUAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

Aggressive periodontitis; Cytokines; Gingival crevicular fluid; Saliva

Indexed keywords

CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGGRESSIVE PERIODONTITIS; ARTICLE; BLEEDING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GINGIVITIS; HUMAN; MALE; MOUTH EXAMINATION; SALIVA;

ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHRONIC PERIODONTITIS; CYTOKINES; FEMALE; GINGIVAL CREVICULAR FLUID; HUMANS; MALE; SALIVA; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84876732005     PISSN: 03936155     EISSN: 17246008     Source Type: Journal    
DOI: 10.5301/jbm.5000014     Document Type: Article

References (28)

1. Highfield J. Diagnosis and classification of periodontal disease. Aust Dent J 2009; 54 (Suppl 1): S11-26.
2. Ozmeric N. Advances in periodontal disease markers. Clin Chim Acta 2004; 343: 1-16.
3. Mattuella LG, Campagnaro MB, Vargas AE, et al. Plasma cytokines levels in aggressive and chronic periodontitis. Acta Odontol Scand 2012 Sep 4 [Epub ahead of print].
4. Socransky SS, Haffajee AD. The bacterial etiology of destructive periodontal disease: current concepts. J Periodontol 1992; 63 (4 Suppl): 322-31.
5. Kidd P. Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. Altern Med Rev 2003; 8: 223-46.
6. Bastos MF, Lima JA, Vieira PM, Mestnik MJ, Faveri M, Duarte PM. TNF-alpha and IL-4 levels in generalized aggressive periodontitis subjects. Oral Dis 2009; 15: 82-7.
7. Rescala B, Rosalem W Jr, Teles RP, et al. Immunologic and microbiologic profiles of chronic and aggressive periodontitis subjects. J Periodontol 2010; 81: 1308-16.
8. Teles RP, Gursky LC, Faveri M, et al. Relationships between subgingival microbiota and GCF biomarkers in generalized aggressive periodontitis. J Clin Periodontol 2010; 37: 313-23.
9. Toker H, Poyraz O, Eren K. Effect of periodontal treatment on IL-1beta, IL-1ra, and IL-10 levels in gingival crevicular fluid in patients with aggressive periodontitis. J Clin Periodontol 2008; 35: 507-13.
10. Zong M, Yang PS, Qi XM, Yi XH. Changes of circulating IFN-gamma, IL-4 in patients with chronic periodontitis before and after periodontal initial therapy. Shanghai journal of stomatology. 2005; 14: 131-133.
11. Tsai CC, Ku CH, Ho YP, Ho KY, Wu YM, Hung CC. Changes in gingival crevicular fluid interleukin-4 and interferon-gamma in patients with chronic periodontitis before and after periodontal initial therapy. Kaohsiung J Med Sci 2007; 23: 1-7.
12. Lamster IB, Ahlo JK. Analysis of gingival crevicular fluid as applied to the diagnosis of oral and systemic diseases. Ann N Y Acad Sci 2007; 1098: 216-29.
13. Armitage GC. Development of a classification system for periodontal diseases and conditions. Northwest Dent 2000; 79: 31-5.
14. Bland JM, Altman DG. Cronbach's alpha. BMJ 1997; 314: 572.
15. Griffiths GS, Wilton JM, Curtis MA, et al. Contamination of human gingival crevicular fluid by plaque and saliva. Arch Oral Biol 1992; 37: 559-64.
16. Lamster IB. Evaluation of components of gingival crevicular fluid as diagnostic tests. Ann Periodontol 1997; 2: 123-37.
17. Lamster IB, Oshrain RL, Fiorello LA, Celenti RS, Gordon JM. A comparison of 4 methods of data presentation for lysosomal enzyme activity in gingival crevicular fluid. J Clin Periodontol 1988; 15: 347-52.
18. Brinkmann O, Spielmann N, Wong DT. Salivary diagnostics: moving to the next level. Dent Today 2012; 31: 54-9.
19. Segal A, Wong DT. Salivary diagnostics: enhancing disease detection and making medicine better. Eur J Dent Educ 2008; 12 (Suppl 1): 22-9.
20. Ebersole JL, Taubman MA. The protective nature of host responses in periodontal diseases. Periodontol 2000 1994; 5: 112-41.
21. Ishikawa I. Host responses in periodontal diseases: a preview. Periodontol 2000 2007; 43: 9-13.
22. Liu CM, Hou LT, Wong MY, Rossomando EF. Relationships between clinical parameters, interleukin 1B and histopathologic findings of gingival tissue in periodontitis patients. Cytokine 1996; 8: 161-7.
23. Mosmann TR, Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 1996; 17: 138-46.
24. Suárez LJ, Ocampo AM, Dueñas RE, Rodríguez A. Relative proportions of T-cell subpopulations and cytokines that mediate and regulate the adaptive immune response in patients with aggressive periodontitis. J Periodontol 2004; 75: 1209-15.
25. Gonzales JR, Gröger S, Boedeker RH, Meyle J. Expression and secretion levels of Th1 and Th2 cytokines in patients with aggressive periodontitis. Clin Oral Investig 2012; 16: 1463-73.
26. Sexton WM, Lin Y, Kryscio RJ, Dawson DR 3rd, Ebersole JL, Miller CS. Salivary biomarkers of periodontal disease in response to treatment. J Clin Periodontol 2011; 38: 434-41.
27. Giannopoulou C, Kamma JJ, Mombelli A. Effect of inflammation, smoking and stress on gingival crevicular fluid cytokine level. J Clin Periodontol 2003; 30: 145-53.
28. Berglundh T, Donati M, Zitzmann N. B cells in periodontitis: friends or enemies? Periodontol 2000 2007; 45: 51-66.